Home/Filings/4/0000899243-22-009376
4//SEC Filing

WEAVER GREGORY L 4

Accession 0000899243-22-009376

CIK 0001840904other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 3:56 PM ET

Size

5.5 KB

Accession

0000899243-22-009376

Insider Transaction Report

Form 4
Period: 2022-03-02
WEAVER GREGORY L
Chief Financial Officer
Transactions
  • Award

    Stock Option

    2022-03-02+228,000228,000 total
    Exercise: $5.65Exp: 2032-03-01Common Shares (228,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

Related Parties

1
  • filerCIK 0001251779

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 3:56 PM ET
Size
5.5 KB